Sleep is not on the standard follow-up checklist for these medications, which are reviewed on weight, dose and gut symptoms. It comes up anyway, usually as an aside at the end of an appointment, and usually described as either the best or the worst thing that has happened.
Both accounts are common, and they tend to belong to different months of the same year.
The large, well-evidenced benefit
Obstructive sleep apnoea is strongly weight-driven for most people who have it. Excess soft tissue around the upper airway narrows it, and it collapses during sleep.
The relationship is quantified better than most things in this field. Longitudinal work found that a ten percent weight gain predicted roughly a thirty-two percent increase in apnoea-hypopnoea index, and a ten percent loss predicted about a twenty-six percent decrease.
SURMOUNT-OSA then tested tirzepatide directly in adults with obesity and moderate-to-severe obstructive sleep apnoea, and found large reductions in apnoea-hypopnoea events against placebo. That result produced the licensed indication, which has become one of the more reliable coverage routes in American insurance — see Zepbound for sleep apnoea and, for how indications drive coverage, do you qualify.
~26%
Predicted fall in apnoea-hypopnoea index from a 10% weight loss
Peppard et al., JAMA 2000
AHI
Apnoea-hypopnoea index — events per hour, the number a sleep study produces
Retest
Apnoea can improve enough that CPAP pressure needs re-titrating after major weight loss
Why the first weeks can be worse
None of these requires a direct effect on sleep architecture. All of them are consequences of a slower gut and a smaller appetite.
Night-time reflux. A stomach that empties at half speed, plus lying flat, plus a late meal. This is the commonest cause of early sleep disruption on these drugs and the most fixable — three hours upright after eating and six to eight inches under the head of the bed. The full set of measures is in reflux on a GLP-1.
Nausea. Clusters one to three days after injection, and is worse lying down. Injecting on a day that puts the peak on a weekend helps more than people expect — see how long side effects last.
Nocturia. Rapid weight loss mobilises fluid, and some of it is excreted at night. Waking two or three times to urinate in the first month is common and settles.
The missing evening meal. Underrated. A large dinner is sedating — the post-prandial dip is real physiology. Remove it and some people simply find themselves more alert at eleven at night than they have been in years.
Hypoglycaemia, for those also on insulin or a sulfonylurea. Night-time lows wake you, sometimes with sweating and a racing heart that is easy to mistake for anxiety. Worth checking rather than assuming — see GLP-1 drug interactions.
The vivid dreams
Reported frequently enough to be worth addressing, studied barely at all.
Two explanations are plausible and neither requires the drug to act on dreaming. Treating sleep apnoea produces REM rebound — people who have been fragmenting their REM sleep for years get it back in quantity, and REM is where vivid dreams live. And any disrupted sleep produces more remembered dreams, simply because waking during REM is what makes a dream memorable.
There is early research interest in GLP-1 receptors in brain regions involved in circadian regulation, but it is a long way from explaining anything a patient is experiencing. The honest position is that this is real, common, usually benign, and not yet accounted for.
Practical adjustments
- Last meal three hours before bed. The single highest-yield change.
- Keep the evening meal lower in fat. Fat slows emptying further, and a heavy dinner is the classic cause of a bad night — see what to eat on a GLP-1.
- Front-load fluid. Drink most of it earlier in the day so hydration does not cost you the night. The reason hydration is not optional is in dehydration and your kidneys.
- Choose your injection day deliberately. Nausea lands one to three days later; put it where it does least damage.
- Raise the head of the bed, on the legs rather than with pillows.
- Expect the first month to be the worst of it. Most of this settles as the gut adapts.
What to raise with a clinician
Loud snoring, witnessed pauses in breathing, waking unrefreshed, or falling asleep during the day all warrant a sleep study — whether or not you are on a GLP-1. A great many people in this population have undiagnosed apnoea, and finding it has two benefits: it is treatable, and it is a qualifying condition that may open a coverage route you did not have.
Insomnia that persists past the first couple of months is unlikely to be the drug and is worth investigating on its own terms.
Most of what looks like a sleep side effect is a full stomach lying flat at midnight. Very little of it is the drug reaching into your sleep.
The trajectory
Rough for four to eight weeks, then better, and for a meaningful number of people better than it has been in a decade.
That improvement is one of the least discussed benefits of this drug class, largely because it does not show up on a scale and nobody photographs it.